
Syngenta agreed to settle lawsuits brought by U.S. corn farmers who claimed it negligently commercialized the Viptera GMO corn seed before China approved it. The article notes that Chinese authorities had rejected millions of tonnes of U.S. corn imports before approving Viptera in December 2014.
The settlement removes litigation risk around GMO corn commercialization but has little direct effect on prices. It is a reminder that biotech approval gaps can disrupt corn export flows to China.
Tras 480 eventos neutral de comercio pasados, Maíz se movió una mediana de +0,2 % en 5 sesiones (54% al alza; mitad central entre -1,1 % y +1,6 %), y +0,7 % en 20.
Variaciones de la referencia de cada materia prima desde el último cierre antes del evento. Las lecturas históricas agrupan eventos pasados del mismo tipo; describen lo ocurrido, no lo que ocurrirá. No es asesoramiento de inversión.